Currency in SEK
| Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 0 | 0 | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.3 | -0.1 |
| Low estimate | 0 | 0 | -0.3 | -0.1 |
| High estimate | 0 | 0 | -0.3 | -0.1 |
| Year ago EPS | N/A | N/A | -0.3 | -0.3 |
| Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | 9M | 22M | 65.5M | 126M |
| Low estimate | 9M | 22M | 65M | 98M |
| High estimate | 9M | 22M | 66M | 154M |
| Year ago sales | 8.76M | 13.27M | 50.9M | 65.5M |
| Sales growth (year/est) | 2.70% | 65.80% | 28.70% | 92.40% |
| Earnings history | Invalid Date | Invalid Date | Invalid Date | 30/06/2022 |
|---|
| Est. EPS | N/A | N/A | N/A | 0 |
| Actual EPS | N/A | N/A | N/A | -0.1 |
| Difference | N/A | N/A | N/A | -0.1 |
| Surprise % | N/A | N/A | N/A | N/A |
| EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| Current estimate | 0 | 0 | -0.3 | -0.1 |
| 7 days ago | 0 | 0 | -0.2 | -0.1 |
| 30 days ago | 0 | 0 | -0.2 | -0.1 |
| 60 days ago | 0 | 0 | -0.17 | -0.08 |
| 90 days ago | 0 | 0 | -0.07 | 0.05 |
| EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | N/A | N/A |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | 1 | N/A |
| Growth estimates | ENZY.ST | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | N/A | N/A | N/A | N/A |
| Next qtr. | N/A | N/A | N/A | N/A |
| Current year | N/A | N/A | N/A | N/A |
| Next year | 66.70% | N/A | N/A | N/A |
| Next 5 years (per annum) | N/A | N/A | N/A | N/A |
| Past 5 years (per annum) | N/A | N/A | N/A | N/A |
